Which one is more effective, avatrombopag or hatrombopag?

Avatrombopag (Avatrombopag) and Herombopag (Herombopag) are two different drugs. If the patient needs to use one of these drugs, it is recommended to treat it under the guidance of a doctor. Both avatrombopag and heltrombopag have undergone clinical trials and have been shown to be effective in increasing platelet counts and improving patient symptoms. Avatrombopag is a selective thrombopoietin receptor agonist (TPO-RAs) approved in the treatment of chronic immune thrombocytopenia (ITP) in adults and is also indicated for the treatment of thrombocytopenia in adult patients with chronic liver disease scheduled to undergo surgery, while hetrombopag is also a TPO-RAs with a similar mechanism of action and has a wider range of indications. In addition to ITP, it is also used for the treatment of thrombocytopenia in patients with cirrhosis.